Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma
Clinical trial NCT03086993 · UNKNOWN
Trial details
- NCT number
- NCT03086993
- Sponsor
- Delcath Systems Inc.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-10
- Primary completion
- 2023-01-01
- Enrollment
- 295
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.